Low Dose Naltrexone's Utility for Non-Cancer Centralized Pain Conditions - A Scoping Review

Pain Med
11 June 2023
https://pubmed.ncbi.nlm.nih.gov/37302106/

Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series

J Pain Res
14 June 2023
https://pubmed.ncbi.nlm.nih.gov/37337611/

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087

Jenny - US: LDN, CRPS and Small Fibre Neuropathy (LDN; low dose naltrexone)

Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force

Pain Pract
29 October 2022
https://pubmed.ncbi.nlm.nih.gov/36308490/

Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374